Opsens to Present at SeeThruEquity Fall Microcap Investor Conference on November 12, 2014 in NYC

QUEBEC CITY, Nov. 11, 2014 /CNW Telbec/ - Opsens Inc. ("Opsens") (TSX-V: OPS) developer of products for the measurement of Fractional Flow Reserve ("FFR") in patients suffering from coronary artery disease is pleased to announce that Louis Laflamme, President and CEO will present at SeeThruEquity's Microcap Investor Conference on Wednesday November 12, 2014.

The one-day event held at the Convene Midtown East in New York City between 8am - 6pm will host a select group of microcap companies. Opsens' President & CEO Louis Laflamme will present to investors and be available for one-on-one meetings during the conference.  

About Opsens Inc. (www.opsens.com)

Focusing on two main growth markets, FFR in medical instrumentation and oil and gas, Opsens develops, manufactures and installs systems to measure pressure, temperature and others parameters using fiber optic sensing technologies. These systems are designed around patented technologies that are effective and durable in extreme conditions. 

About SeeThruEquity, LLC (www.seethruequity.com)

SeeThruEquity is an equity research and corporate access firm focused on companies with less than $1 billion in market capitalization. The research is not paid for and is unbiased. The company does not conduct any investment banking or commission based business.  SeeThruEquity is approved to contribute its research to Thomson Reuters One (First Call), CapitalIQ, FactSet, and Zacks and distribute its research to its database of opt-in investors. The company also contributes its estimates to Thomson Estimates, the leading estimates platform on Wall Street.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements contained in this press release involve known and unknown risks, uncertainties and other factors that may cause actual results, performance and achievements of Opsens to be materially different from any future results, performance or achievements expressed or implied by the said forward-looking statements.

SOURCE: OPSENS INC.

Thierry Dumas, CPA, CA, Chief Financial Officer, 418.682.9996; Louis Laflamme, CPA, CA, President and Chief Executive Officer, 418.682.9996